Choosing a pharmaceutical company that produces high-quality oncology medicines is crucial, especially as the demand for cancer treatment surges. In India, one in nine individuals is diagnosed with cancer in their lifetime, with each case presenting unique challenges. Meeting the diverse needs of patients is critical, as changing lifestyles impact genes and immune systems. Top oncology drug manufacturers are innovating efficient, targeted therapies and making them available at affordable prices. The companies listed below have been shortlisted for their advancements in:
- Producing targeted therapy
- Developing anti-tumor drug formulations
- Nanoparticle-based treatments
Best Oncology Medicine Manufacturers
Oncology medicine manufacturers in India have taken a significant stride in the last few years to reduce the tolling cancer rate worldwide. Top oncology drug manufacturers have expanded their distribution to the needed markets, formulating more easily integrated, effective solutions and partnering with industry leaders to produce innovative solutions.
Pinnacle Life Science
Pinnacle is among the top oncology pharma companies. We produce various forms of oncology medicines in specified dosage ranges. Along with anticancer drugs, Pinnacle also produces various other therapeutic solutions. Our GMP-certified facility rolls out more than 3 billion tablets and 300 million capsules every single year. We are a leading exporter to over 90 countries.
Our approach focuses on accessibility, ensuring that our medicines reach everyone. By producing more effective solutions, we drastically reduce the number of doses a patient needs to take. At the same time, our varied forms of drugs, including chewable tablets, effervescent formulations, direct compressions, and IR & DR solid dosages, help patients at all stages of treatment administer the medicine easily.
Pinnacle demonstrates diversity in its cancer drug manufacturing by developing targeted drugs. As cancer progresses, treatment needs to evolve. Relying solely on chemotherapy can sometimes reduce its effectiveness. To address changes in cancer-based on genetic mutations, biomarkers, and patient tolerance levels, we offer a range of drugs and dosages tailored to meet those needs. Our treatments target:
- Prostate cancer
- Chronic myeloid leukemia (CML)
- HER2-negative breast cancer
- Colorectal cancer
- Metastatic colorectal cancer
We are a cutting-edge R&D team of 15 well-established scientific professionals. In addition to developing generic formulations, we also provide contract manufacturing services to help your organization expand its product portfolio and scale.
Cipla Ltd
Cipla is a global leader in the pharmaceutical industry. It has optimized its diverse oncology portfolio, which includes 32 different targeted formulations. The company has over 47 sites worldwide, each with its own resources, supported by a well-experienced team of experts. From API production to conducting extensive clinical research—all handled in-house.
What separates Cipla from other oncology pharmaceutical companies is its use of nanotechnology in paclitaxel injections. It doesn’t just reduce the toxicity level in the drug but also improves its effectiveness. Not to mention, this greatly reduces the harmful side effects in patients.
In addition to producing generic and complex molecules, Cipla is also interested in partnerships, collaborating with leading firms like Pfizer to produce custom solutions for regional deficiencies in cancer treatment.
Lupin Limited
Lupin is known for its multifaceted production capabilities. Its therapeutic areas range from immunology to metabolic disorders and oncology. The oncology production facility is located in Indore, where it handles its high-potency developments. Apart from that, it has over 15 manufacturing sites spread across the world, all of which comply with international regulatory standards.
They recently produced a generic version of a liposome injection for ovarian cancer. Lupin is an active proponent on the lookout for partnering with global leaders, as they previously collaborated with AbbVie, a biopharmaceutical company, in 2018 to develop a novel oncology drug targeting hematological cancers. They are constantly evolving their product portfolio to break through to new markets.
Dr. Reddy’s Laboratories Ltd
Dr. Reddy is a major oncology/anticancer API producer in India. A highly experienced team provides key ingredients like kinase inhibitors, androgen receptor inhibitors, and microtubule inhibitors. The company has designed a well-contained facility adhering to GMP regulations. They address the high potency of the APIs by following the QbD process, which also helps ensure that these anticancer drugs are free of genotoxic impurities and of high quality.
Getwell Pharma
Getwell Pharma focuses on manufacturing sterile oncology injectables using advanced isolator fill-finish processes. They have two sterile oncology manufacturing facilities based in Haryana. One handles liquid vials and dry powder injections, while the other is equipped with advanced technologies, particularly optimized for an automatic integrated isolator-based liquid vial filling line. Getwell Pharma produces more than 35 anticancer medicines that broadly cover solid tumors and hematological malignancies.
Aurobindo Pharma Limited
Aurobindo specializes in producing lyophilized formulations (freeze-drying), a crucial process required for oncology drugs to stabilize sensitive cancer therapeutics. They follow a vertical integration model, from synthesizing API to dosage formulation, to ensure clean quality across the supply chain. Their varied oncology portfolio consists of niche molecules, including next-generation kinase inhibitors and immuno-oncology agents.
It is one of the few manufacturers capable of producing APIs in bulk quantities in India. Aurobindo also supports tailored regulatory compliance for its partners, including dossier preparation and filing, addressing queries, and lifecycle management for oncology products.
Torrent Pharmaceuticals
Torrent Pharmaceuticals features both generic and proprietary formulations, including treatments for blood cancer and solid tumors. Headquartered in Ahmedabad, Gujarat, Torrent operates in over 40 countries, with more than 2,000 registered products globally.
Choose your Contract Manufacturer for Cancer Treatment
These cancer drug manufacturing companies are making cancer treatments more accessible and effective. They address the need for large-scale production as well as specialized, high-potency formulations. If you’re looking for a growing oncology drug developer, Pinnacle Lifesciences is the one to choose.
Our contract manufacturing services will not only help you obtain our generic formulations but also assist in developing new, more targeted formulations tailored to your regional patients. To learn more about our end-to-end oncology solutions, explore our extensive portfolio or contact us here.
